CheckMyRecalls

Alembic Pharmaceuticals Limited recalls Fesoterodine Fumarate

Published
14 Jan 2026
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30

Brand / company
Alembic Pharmaceuticals Limited
Codes / lots
Lot# 2405003360, Exp Date: Jan 31, 2026
Distribution
US Nationwide and PR.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 14 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.